These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33488123)

  • 41. LncRNA
    Chen X; Huang Y; Shi D; Nie C; Luo Y; Guo L; Zou Y; Xie C
    Onco Targets Ther; 2020; 13():4397-4409. PubMed ID: 32606725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BBOX1-AS1 Accelerates Nasopharyngeal Carcinoma Progression by Sponging miR-3940-3p and Enhancing KPNA2 Upregulation.
    Jiang H; He Q; Liu T
    Cancer Manag Res; 2021; 13():9049-9062. PubMed ID: 34938119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5.
    Li S; Zhao B; Zhao H; Shang C; Zhang M; Xiong X; Pu J; Kuang B; Deng G
    Front Oncol; 2019; 9():1246. PubMed ID: 31921616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNA TMPO-AS1 facilitates chemoresistance and invasion in breast cancer by modulating the miR-1179/TRIM37 axis.
    Ning X; Zhao J; He F; Yuan Y; Li B; Ruan J
    Oncol Lett; 2021 Jul; 22(1):500. PubMed ID: 33981362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA RGMB-AS1 Promotes Glioma Growth and Invasion Through miR-1200/HOXB2 Axis.
    Pan B; Zhao M; Wang N; Xu L; Wu T; Li Z
    Onco Targets Ther; 2019; 12():10107-10114. PubMed ID: 31819505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.
    Chang H; Yao Y
    Bioengineered; 2022 Feb; 13(2):2889-2901. PubMed ID: 35040749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ZNRD1-AS1 Promotes Nasopharyngeal Carcinoma Cell Invasion and Metastasis by Regulating the miR-335-ROCK1 Axis.
    Wang Q; Hu X; Du M; Lu Z; Yan K; Zhao D; Jiang N; Peng Y; He X; Yin L
    Onco Targets Ther; 2020; 13():4779-4790. PubMed ID: 32547105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
    Qin Z; Zheng X; Fang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA ADAMTS9-AS1 Restrains the Aggressive Traits of Breast Carcinoma Cells via Sponging miR-513a-5p.
    Fang S; Zhao Y; Hu X
    Cancer Manag Res; 2020; 12():10693-10703. PubMed ID: 33149676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143.
    Dong P; Wang F; Taheri M; Xiong Y; Ihira K; Kobayashi N; Konno Y; Yue J; Watari H
    Front Oncol; 2022; 12():912935. PubMed ID: 35712514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346.
    Pan R; He Z; Ruan W; Li S; Chen H; Chen Z; Liu F; Tian X; Nie Y
    Onco Targets Ther; 2018; 11():8409-8420. PubMed ID: 30555237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma.
    Zhong LK; Zhou J; He X; He BF; Zhou XW; Zhu JL; Liu J; Qiu YH
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8008-8016. PubMed ID: 32767327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A long non-coding RNA with important roles in the carcinogenesis.
    Ghafouri-Fard S; Askari A; Hussen BM; Taheri M; Mokhtari M
    Front Cell Dev Biol; 2022; 10():1037149. PubMed ID: 36467407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA TTC28-AS1 attenuates high glucose-induced damage in HK-2 cells depending on the regulation of miR-320a/CD2AP axis.
    Zhang J; Ding J; Yu M; Li F; Zhou X; Shuai H
    Genes Genomics; 2021 Dec; 43(12):1471-1482. PubMed ID: 34623609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of lncRNA NCK1-AS1 Inhibits Cancer Cell Migration and Invasion in Nasopharyngeal Carcinoma by Upregulating miR-135a.
    Hu H; Li H; Feng X
    Cancer Manag Res; 2019; 11():10531-10537. PubMed ID: 31908525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.
    Zhang C; Yang H; Li Y; Huo P; Ma P
    Mol Cell Biochem; 2020 Apr; 467(1-2):15-25. PubMed ID: 32072428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.